Cartesian Therapeutics (RNAC) EPS (Basic) (2015 - 2026)
Cartesian Therapeutics (RNAC) reported EPS (Basic) of -$1.46 for Q1 2026, down 114.71% year-over-year from $9.93 in Q1 2025, and up 59.1% quarter-over-quarter from -$3.57 in Q4 2025.
Cartesian Therapeutics (RNAC) EPS (Basic) (2015 - 2026) Analysis & Trends
Cartesian Therapeutics (RNAC) has 12 years of EPS (Basic) data on file, last reported at -$1.46 in Q1 2026.
- EPS (Basic) for Q1 2026 came in at -$1.46, down 114.71% year-over-year; the trailing twelve-month figure through Mar 2026 was -$5.9 (down 436.36% YoY), and the FY2025 annual result was -$5.02, down 12.05% from the prior year.
- EPS (Basic) rose to -$1.46 in Q1 2026 per RNAC's latest filing, from -$3.57 in the prior quarter.
- Over five years, EPS (Basic) peaked at $0.58 in Q2 2024 and troughed at -$41.56 in Q4 2023.
- A 5-year average of -$3.94 and a median of -$1.13 in 2024 frame the typical range for EPS (Basic).
- The sharpest annual moves came in 2022 and 2023: EPS (Basic) surged 204.55% in 2022, then slumped 138633.33% in 2023.
- A 5-year view of EPS (Basic) shows it stood at $0.03 in 2022, then tumbled by 138633.33% to -$41.56 in 2023, then soared by 100.31% to $0.13 in 2024, then tumbled by 2846.15% to -$3.57 in 2025, then jumped by 59.1% to -$1.46 in 2026.
- Business Quant data shows RNAC's EPS (Basic) at -$1.46 in Q1 2026, -$3.57 in Q4 2025, and -$1.38 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -0.68 |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.06 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.00 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 0.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 0.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 0.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 4.06 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -0.06 |
| 10 | Cartesian Therapeutics | 261.84 Mn | 261.84 Mn | - | -1.46 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.46 |
| Dec 31, 2025 | -3.57 |
| Sep 30, 2025 | -1.38 |
| Jun 30, 2025 | 0.51 |
| Mar 31, 2025 | -0.68 |
| Dec 31, 2024 | 0.13 |
| Sep 30, 2024 | -1.13 |
| Jun 30, 2024 | 0.58 |
| Mar 31, 2024 | -10.50 |
| Dec 31, 2023 | -41.56 |
| Sep 30, 2023 | -1.74 |
| Jun 30, 2023 | -2.23 |
| Mar 31, 2023 | -4.24 |
| Dec 31, 2022 | 0.03 |
| Sep 30, 2022 | -0.05 |
| Jun 30, 2022 | 0.06 |
| Mar 31, 2022 | 0.23 |
| Dec 31, 2021 | 0.12 |
| Sep 30, 2021 | -0.16 |
| Jun 30, 2021 | 0.04 |